𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial

✍ Scribed by Kodjikian, Laurent; Souied, Eric H.; Mimoun, Gérard; Mauget-Faÿsse, Martine; Behar-Cohen, Francine; Decullier, Evelyne; Huot, Laure; Aulagner, Gilles


Book ID
121720251
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
770 KB
Volume
120
Category
Article
ISSN
0161-6420

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES